Various permissive homeostatic signals must be integrated to achieve ovulation in mammals. However, the neural events controlling the timely activation of GnRH neurons are not completely understood. Here we show that kisspeptin, a potent activator of GnRH neuronal activity, directly communicates with neurons that synthesize the gaseous transmitter nitric oxide (NO) in the preoptic region to coordinate the progression of the ovarian cycle. Using a transgenic Gpr54-null IRES-LacZ knock-in mouse model, we demonstrate that neurons containing neuronal NO synthase (nNOS), which are morphologically associated with kisspeptin fibers, express the kisspeptin receptor GPR54 in the preoptic region, but not in the tuberal region of the hypothalamus. The activation of kisspeptin signaling in preoptic neurons promotes the activation of nNOS through its phosphorylation on serine 1412 via the AKT pathway and mimics the positive feedback effects of estrogens. Finally, we show that while NO release restrains the reproductive axis at stages of the ovarian cycle during which estrogens exert their inhibitory feedback, it is required for the kisspeptin-dependent preovulatory activation of GnRH neurons. Thus, interactions between kisspeptin and nNOS neurons may play a central role in regulating the hypothalamic-pituitary-gonadal axis in vivo.
Introduction
The survival of a mammalian species depends on the ability of its individuals to quickly, effectively, and reliably transmit homeostatic signals to the hypothalamic neuronal population that releases gonadotropin-releasing hormone (GnRH) and controls reproduction. This requires the mediation of neural networks that sense moment-to-moment changes in physiological inputs throughout life (Wintermantel et al., 2006; Mayer et al., 2010; Donato et al., 2011; Mayer and Boehm, 2011) . We hypothesized that interactions between hypothalamic neurons expressing kisspeptin and those expressing neuronal nitric oxide synthase (nNOS) could be of particular importance in regulating the neuroendocrine output of GnRH neurons during the ovarian cycle, as the mutation of either of these causes infertility in mice (Gyurko et al., 2002; d'Anglemont de Tassigny et al., 2007b; Lapatto et al., 2007) .
In rodents, GnRH neurons are predominantly located in the preoptic region of the ventral forebrain. They project to the median eminence of the hypothalamus, where GnRH is released into portal blood vessels for delivery to the anterior pituitary. In the pituitary, GnRH elicits the secretion of luteinizing hormone (LH) and follicle-stimulating hormone, which stimulate gametogenesis and gonadal hormone secretion and thus support reproductive function. In recent years, kisspeptin and its receptor GPR54 (also known as KISS1R) have emerged as key players in the regulation of GnRH/LH release (Oakley et al., 2009; d'Anglemont de Tassigny and Colledge, 2010; Navarro and Tena-Sempere, 2011) . Kisspeptin-expressing neurons, which are found primarily in the hypothalamus, directly innervate and stimulate the electrical activity of GnRH neurons, which express the kisspeptin receptor GPR54 ). Mice with a targeted deletion of Gpr54 are sterile (Funes et al., 2003; Seminara et al., 2003; Dungan et al., 2007; Kauffman et al., 2007; Lapatto et al., 2007) , and kisspeptin-GPR54 signaling appears essential for the GnRH neuronal activation that initiates ovulation (Clarkson et al., 2008) . In addition to acting directly on GnRH neurons, an increasing body of evidence suggests that kisspeptin also operates on unidentified neurons to modulate the strength of synaptic afferents and regulate GnRH secretion (Pielecka-Fortuna et al., 2008) . Nitric oxide (NO), a gaseous neurotransmitter known for its important role in regulating neuronal transmission (Garthwaite, 2008 ) and the neuroendocrine control of reproduction (Bellefontaine et al., 2011) , has recently been implicated in the regulation of GnRH neuronal activity (Clasadonte et al., 2008) . This NO is produced in the vicinity of GnRH-containing perikarya by neurons expressing nNOS (Clasadonte et al., 2008) , an enzyme whose activity has been shown to be tightly regulated by estrogens during the ovarian cycle in rats (d'Anglemont de Tassigny et al., 2007a; Parkash et al., 2010) .
We investigated whether kisspeptin-positive neurons projected onto nNOS neurons, and whether kisspeptin signaling in these cells could contribute to the hypothalamic control of reproduction. Using genetic mouse models, we demonstrate that kisspeptin neurons directly act on NO-synthesizing neurons to promote preovulatory nNOS activation and that these interactions modulate LH secretion.
Materials and Methods

Animals
Experiments were performed on adult (2-3 months old) female C57BL/6J (Charles River Laboratories) and nNOS-null mice (Huang et al., 1993 ) (Jax mice; Jackson Laboratory), Gpr54-null mice (Seminara et al., 2003) , Kiss1-null mice (d'Anglemont de Tassigny et al., 2007b) , and their wild-type littermates. Genotypes were determined by PCR as reported previously (Huang et al., 1993; Seminara et al., 2003; d'Anglemont de Tassigny et al., 2007b) . Mice were housed under a 12 h:12 h lighting schedule with ad libitum access to food and water. For most of the experiments, vaginal smears were taken daily to identify the specific day of the estrous cycle. All experiments were performed in accordance with the guidelines for animal use specified by the European Communities Council Directive of November 24th, 1986 (86/ 609/EEC) regarding mammalian research and were approved by the University of Lille 2 Animal Use Committee, or following the United Kingdom Home Office Project License and were approved by the Cambridge Animal Ethics Committee.
Drugs
Synthetic kisspeptin-10 [rodent metastin (45-54) amide; YY-10-NH 2 ] was purchased from GeneCust. The NOS inhibitor N-G-nitro-L-arginine methyl ester, HCl (L-NAME), the PI3-kinase inhibitor LY294002 (440202), the MEK inhibitor U0126 (662005), and DMSO (317275) were purchased from Calbiochem. 17␤-Estradiol 3-benzoate (E8515), 17␤-estradiol (E8875), progesterone (P0130), and sesame oil (S3547) were purchased from Sigma.
Antibodies
Immunofluorescence. The sheep polyclonal anti-nNOS antibody (1:3000) was a generous gift from Dr. P. C. Emson (Laboratory for Molecular Biology, Cambridge, UK) (Herbison et al., 1996) . The rabbit polyclonal anti-kisspeptin antibody (1:5000; AC-566) was a generous gift from Dr. Alain Caraty (Institut National de la Recherche Agronomique, Tours, France) (Franceschini et al., 2006) . The rabbit polyclonal anti-GnRH (1:3000) was a generous gift from Prof. G. Tramu (Université Bordeaux I, Talence, France) (Beauvillain and Tramu, 1980) . The rabbit polyclonal antiphosphorylated nNOS (Ser 1412 ) antibody (71-8600; 1:500) was purchased from Affinity BioReagents. The Alexa Fluor 568-conjugated donkey anti-sheep secondary antibody (A-21099; 1:500) used for nNOS immunolabeling, the Alexa Fluor 488-conjugated donkey anti-rabbit secondary antibody (A21206; 1:500) used for GnRH and P-nNOS immunolabeling, and the streptavidin-conjugated Alexa Fluor 488 (S32354; 1:500) used for kisspeptin detection were purchased from Invitrogen. A biotinylated donkey anti-rabbit secondary antibody (711-065-152; 1:500) was purchased from Jackson ImmunoResearch.
Western Blotting. The rabbit polyclonal anti-nNOS (sc-8309; 1:500) and goat polyclonal anti-actin (sc-1616; 1:1000) antibodies were purchased from Santa Cruz Biotechnology. The rabbit polyclonal antiphospho-nNOS antibody (Ser 1412 ; PA1-032; 1:1000) was purchased from Affinity BioReagents. The rabbit monoclonal anti-phospho-Akt (Ser 473 ; #4060S; 1:1000), rabbit monoclonal Akt (#4691S; 1:1000), rabbit polyclonal anti-phospho-p44/42 MAPK (p-Erk1/2; Thr 202 /Tyr 204 ; #9101L; 1:1000), and rabbit polyclonal anti-p44/42 MAPK (Erk1/2; #9102L; 1:1000) antibodies were purchased from Cell Signaling Technology. HRP-conjugated secondary antibodies (1:10,000) were purchased from Sigma.
Immunohistofluorescence
Animals were deeply anesthetized with chloral hydrate (400 mg/kg, i.p.) and perfused transcardially with saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4. Brains were removed and immersed in the same fixative for 2 h at 4°C and stored in PB until slicing. Free-floating coronal sections (60 M thick) containing the preoptic region were cut on a Vibratome (VT1000S; Leica), collected in ice-cold PB, incubated in blocking buffer [PBS containing 5% normal donkey serum (D9663; Sigma) and 0.3% Triton X-100 (Sigma)] for 1 h at room temperature (RT) and then incubated with sheep polyclonal anti-nNOS (1: 1000) and rabbit polyclonal anti-kisspeptin (1:5000), or rabbit polyclonal anti-P-nNOS (Ser 1412 ; 1:500) primary antibodies prepared in blocking solution for 48 h at 4°C. Sections were rinsed thoroughly four to five times in PBS and exposed to secondary antibodies, first with Alexa Fluor 568-conjugated donkey anti-sheep and biotinylated donkey antirabbit antibodies in blocking solution for 1 h at RT and then with streptavidin-conjugate Alexa Fluor 488. Kisspeptin immunoreactivity was localized with a biotinylated donkey antirabbit IgG (1:500; Vector Laboratories). Tyramide signal amplification was accomplished by placing the sections in an avidin-biotin solution (Vectastain) for 1 h, followed by incubation in tyramide signal-amplification solution for 20 min, according to the manufacturer's instruction (TSA-Indirect kit; New England Nuclear Life Science). Deposited biotin was detected with Alexa 488-conjugated streptavidin (1:500; Invitrogen). After washing, sections were mounted on glass slides and coverslipped with Permafluor medium (434990; Immunon). Double-immunofluorescent images were acquired using an Axio Imager.Z1 ApoTome microscope (AxioCam MRm camera, AxioVision 4.6 software system; Zeiss). For illustration purposes, photomontages of the preoptic region were prepared with the help of Photoshop CS4 software (Adobe) using digitalized images acquired with a 20ϫ objective (NA, 0.5). Single-labeled nNOS neurons and duallabeled P-nNOS/nNOS were quantified in the upper focal plane of sections (60 M thick) in different parts of the preoptic region using digitalized images. For confocal observation and analyses, an inverted laser scanning Axio observer microscope (LSM 710; Zeiss) with an EC Plan NeoFluor 100ϫ/1.4 NA oil-immersion objective (Zeiss) was used (Imaging Core Facility, University of Lille 2, France).
X-gal histochemistry coupled with GnRH/nNOS double-immunocytochemistry
Free-floating, 40-M-thick sections were cut on a cryostat from adult Gpr54-null mouse brains processed as described (see Immunohistofluorescence, above). A series of sections containing the preoptic and tuberal region of the hypothalamus was washed thoroughly with 0.1 M PBS, pH 7.4, and placed in 2% 5-bromo-4-chloro-3-indoyl-␤-D-galactosidase (Xgal) solution [2 mM MgCl 2 , 4 mM K 3 Fe(CN) 6 , 4 mM K 4 Fe(CN) 6, and 4 mg/ml X-gal] overnight at RT. After PBS washes and preincubation in blocking buffer (PBS containing 5% donkey serum and 0.05% Triton X-100) for 1 h at RT, sections were incubated with rabbit anti-GnRH (1:3000) and sheep anti-nNOS (1:3000) primary antibodies diluted in blocking buffer at 4°C overnight. After PBS rinses, sections were incubated with Alexa Fluor 488-conjugated donkey anti-rabbit (1:500) and Alexa Fluor 568-conjugated donkey anti-sheep (1:500) antibodies diluted in blocking buffer for 2 h at RT. Sections were rinsed thoroughly, mounted on glass slides, and coverslipped with Permafluor medium (434990; Immunon).
Sections were examined using an Axio Imager.Z1 ApoTome microscope (Zeiss) equipped with a motorized stage and an AxioCam MRm camera (Zeiss). Specific filter cubes were used for the visualization of GnRH immunoreactivity in green (excitation filter: 475/40 nm; dichroic mirror: 500 nm; barrier filter: 530/50 nm) and nNOS immunoreactivity in red (excitation filter: 550/25 nm; dichroic mirror: 570 nm; barrier filter: 605/70 nm); X-gal staining was visualized simultaneously by switching to brightfield. GnRH or nNOS cells were considered X-gal-positive if the X-gal reaction product was found within the cytoplasm of the soma or proximal dendrite. X-gal/GnRH double-labeled cells, X-gal/nNOS doublelabeled cells, X-gal-labeled unidentified cells, and single-labeled GnRH or nNOS cells were counted. Analysis was performed by counting all single-labeled and double-labeled cells in two sections from each animal corresponding to plates 17-21 of the Swanson brain atlas (Swanson, 2004) , focusing on the medial septal nucleus, the organum vasculosum of the lamina terminalis, the median preoptic nucleus, the anteroventral preoptic nucleus (in which nNOS neurons are known to interact morphologically with GnRH neurons), and the arcuate nucleus of the hypothalamus [a kisspeptin neuron-containing structure (Oakley et al., 2009; Navarro and Tena-Sempere, 2011) adjacent to the median eminence, to which GnRH neurons project]. Values from each mouse were used to determine mean counts and data are represented as means Ϯ SEM.
For illustration purposes, photomontages of different parts of the preoptic region containing GnRH/nNOS-immunoreactive neurons along with X-gal staining in brightfield were prepared with the help of Photoshop CS4 software (Adobe), using digitalized images acquired with a 20ϫ objective (NA, 0.5) (Zeiss).
Protein extraction
The preoptic region was dissected from each animal and protein extracted for Western blotting as described previously (d 'Anglemont de Tassigny et al., 2007a; Parkash et al., 2010) . Briefly, mice were killed by decapitation following treatment. After the rapid removal of the brain, the meninges and optic chiasm were removed and the preoptic region was dissected under a binocular magnifying glass with the Wecker scissors (Moria). The external limits for this dissection were as follows: laterally, the external border of the medial preoptic area; and dorsally, the internal border of the anterior commissures. Anteroposteriorly, the dissected region was comprised between the atlas levels 16 and 20 (Swanson, 2004) . The tuberal region of the hypothalamus was similarly dissected; the external limits for this dissection were as follows: laterally, the external border of the lateral hypothalamic area; and dorsally, the roof of the third ventricle. Anteroposteriorly, the dissected region was comprised between atlas levels 26 and 31 (Swanson, 2004) . After dissection, each fragment was placed in a microcentrifuge tube, snap frozen in liquid nitrogen, and stored at Ϫ80°C.
Protein extracts were prepared from each preoptic region sample in 200 l of lysis buffer (25 mM Tris, pH 7.4, ␤-glycerophosphate, 1.5 mM EGTA, 0.5 mM EDTA, 1 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 10 g/ml leupeptin and pepstatin A, 10 g/ml apoprotinin, 100 g/ml PMSF, and 1% Triton X-100) by homogenization of the fragments through 22 and 26 gauge needles in succession. Tissue lysates were cleared by centrifugation at 14,000 rpm for 15 min at 4°C. Protein content was determined using the Bradford method (Bio-Rad) and equal amounts of protein were mixed with 4ϫ sample buffer (Invitrogen). Samples were boiled for 5 min and stored at Ϫ80°C until use.
Western blot analyses
Samples were reboiled for 5 min after thawing and electrophoresed for 75 min at 150 V in 7% Tris-acetate, or for 50 min at 200 V in precast 4 -12% MES SDS-polyacrylamide gels according to the protocol supplied with the NuPAGE system (Invitrogen). After size fractionation, the proteins were transferred onto 0.2 m pore-size polyvinylidene difluoride membranes (LC2002; Invitrogen) in the blot module of the NuPAGE sytem (Invitrogen) for 75 min at RT. Membranes were blocked for 1 h in blocking buffer [TBS with 0.05% Tween 20 (TBST) and 5% nonfat milk] at RT, and incubated overnight at 4°C with the appropriate primary antibody diluted in blocking buffer. Membranes were washed four times with TBST the following day before being exposed to HRP-conjugated secondary antibodies diluted in blocking buffer for 1 h at RT. Immunoreactions were visualized using the ECL detection kit (NEL101; PerkinElmer). When stripping and reprobing was required, membranes were incubated in a stripping solution (62.5 mM Tris-HCl, 2% SDS, pH 6.7, and 100 mM ␤-mercaptoethanol) for 30 min with gentle rocking at 65°C. An HRP-conjugated secondary antibody was used to verify that all former immunoreactivity had been successfully stripped away. Immunoblots were scanned using a desktop scanner (Epson Expression 1680 PRO) and Adobe Photoshop, and band intensities were determined using ImageJ software (NIH).
Kisspeptin-10 treatment
Diestrous mice received a single intraperitoneal injection of 100 l of PBS containing 1 nmol Kisspeptin-10 (Kp10) or PBS only. After 30 min, mice were either killed by decapitation and the hypothalamic preoptic 
Mouse treatment with PI3 kinase, MAPK, and NOS inhibitors
Ovariectomized mice received a single injection of LY294002 (100 mg/ kg, i.p.) or U0126 (30 mg/kg, i.p.) or DMSO. After 30 min, animals received a single intraperitoneal injection of 100 l PBS containing 1 nmol of Kp10 or PBS only. After an additional 30 min, mice were killed by decapitation and the preoptic region of each brain dissected from each brain and processed for Western blotting. For L-NAME treatment, diestrous or ovariectomized mice first received a single injection of the NOS inhibitor (50 mg/ kg, i.p.) or PBS; 3 h later, they were given a second injection of either Kp10 or PBS, and killed after 30 min by decapitation. Trunk blood was collected in tubes containing EDTA (0.2 M) and centrifuged at 6500 rpm for 15 min at 4°C; the supernatant obtained ( plasma) was stored at Ϫ80°C until ELISA for LH.
Estradiol treatment in ovariectomized mice
Gpr54-null mice and their wild-type littermates were bilaterally ovariectomized (day 0) under anesthesia with an intraperitoneal injection of 60 mg/kg ketamine and 10 mg/kg xylazine. On the 15th day after ovariectomy (Day 15) at 9:00 A.M., mice received either a single subcutaneous injection of estradiol benzoate (E 2 ; 1 g/20 g body weight in sesame oil) or vehicle alone. Mice were killed by decapitation on Day 17 between 6:30 and 7:30 P.M., and the hypothalamic preoptic region was dissected and processed for Western blotting. This protocol has previously been used to assess the effect of the preovulatory rise in estrogen levels on the phosphorylation of nNOS protein in the preoptic region (Parkash et al., 2010) .
Steroid-induced LH surge protocol
Mice were bilaterally ovariectomized as described in the previous paragraph, and implanted subcutaneously with SILASTIC capsules containing E 2 (1 g/20 g body weight). The SILASTIC capsules were prepared as follows: crystalline E 2 was dissolved in absolute ethanol, mixed with SILASTIC medical adhesive (Type A; Dow Corning) at a concentration of 0.1 mg/ml adhesive and injected into SILASTIC tubing (internal diameter, 1 mm; external diameter, 2.125 mm; Dow Corning) (Bronson, 1981; Clarkson et al., 2008) . Six days after ovariectomy, mice received a single subcutaneous injection of 17␤-estradiol 3-benzoate (1 g/20 g of body weight in sesame oil) at 9:00 A.M. The following day, animals received another injection of progesterone (500 g/20 g body weight, s.c., in sesame oil) at 9:00 A.M. Between 7:30 and 8:30 P.M (lights off at 8:00 P.M.) on the same day, mice were anesthetized with an overdose of chloral hydrate (400 mg/kg; i.p.) and trunk blood was collected for LH assay.
Luteinizing hormone assay
Plasma LH was measured using Rodent LH ELISA kit (ERKR7010-A; Endocrine Technologies) with a sensitivity of 0.3 ng/ml and 7% intraassay and 10% interassay coefficients of variation.
Ovarian histology
Dissected ovaries were fixed in 4% paraformaldehyde, washed in PBS, wax embedded in paraffin, sectioned at 5 m intervals, and stained with hematoxylin and eosin. 
Estrous cyclicity
To examine the possible effects of mutations on estrous cyclicity, vaginal lavages from adult (Ͼ2 months old) female nNOS-null mice and their wild-type littermates were performed everyday in the morning (10:00 A.M. to 1:00 P.M.) using 0.9% saline. The smears were observed under the microscope and the phase identified as diestrus (L) if they predominantly contained leukocytes, as proestrus (N) if they predominantly contained basal and cornified nucleated cells, and as estrus (C) if they predominantly contained cornified epithelial cells. An estrous cycle was considered normal when the vaginal lavage had leukocytes for 2 d followed by 1 d of nucleated and 1-2 d of cornified cells.
Statistics
Differences between two groups were analyzed by Student's t test. Differences between several groups were analyzed using one-way ANOVA, followed by the Student-NewmanKeuls multiple-comparison test for unequal replication. The level of significance was set at p Ͻ 0.05.
Results
Subsets of NO-synthesizing neurons are abundantly surrounded by kisspeptinimmunoreactive fibers in the preoptic region To determine whether kisspeptin neurons morphologically interact with nNOS neurons in the preoptic region, we performed dual immunofluorescent-labeling studies using well characterized antibodies to kisspeptin (Fig. 1A) ) and to nNOS (Herbison et al., 1996) . Fluorescence microscopic examinations were conducted in forebrain areas in which nNOS and GnRH neurons are known to interact morphologically and functionally in mice (n ϭ 4 mice) (Clasadonte et al., 2008) . They clearly establish the existence of distinct populations of NO-synthesizing neurons that are morphologically associated with kisspeptin-immunoreactive fibers (Figs. 1B,  2) . Notably, in the median preoptic nucleus (MePO) and the organum vasculosum of the lamina terminalis (OVLT), kisspeptinimmunoreactive fibers were found to be abundantly apposed to nNOS-containing cell bodies (Fig. 2C,E) , whereas in the medial septum (MS) and the anteroventral preoptic nucleus (AVP), virtually no apposition was seen between kisspeptin-immunoreactive axons and the cell bodies of nNOS neurons (Fig. 2B,F) .
NO-synthesizing neurons in the OVLT and MePO express GPR54
Using a transgenic GPR54-LacZ knock-in mouse model, we next sought to test the intriguing possibility that nNOS neurons in the preoptic region could express GPR54. X-gal histochemistry coupled with double-immunofluorescence labeling revealed that in the OVLT and MePO, LacZ and, by extension, GPR54, was not only contained in GnRH neurons as previously described (Messager et al., 2005; Herbison et al., 2010) , but also in nNOS neurons (Fig. 3) . Quantitative analyses showed that 25 Ϯ 5% and 41 Ϯ 4% of X-gal-positive cells in the OVLT and 23 Ϯ 2% and 57 Ϯ 6% of X-gal-positive cells in the MePO were GnRH and nNOS neurons, respectively (n ϭ 4 female mice). In contrast, X-gal staining in the MS was restricted to GnRH neurons (9 Ϯ 2% of X-gal-positive cells) and a population of nNOS-immunonegative cells (Fig. 3A,B) ; in the AVP, GnRH neurons were the only X-galpositive cells (Fig. 3E,H) . Together with our data showing that kisspeptin-containing fibers are closely apposed to nNOS neurons in the OVLT-MePO, these results strongly suggest that kisspeptin, the ligand for GPR54, may act directly on these neurons.
NO-synthesizing neurons are surrounded by kisspeptinimmunoreactive fibers in the arcuate nucleus of the hypothalamus, but do not express the GPR54 kisspeptin receptor
In the mouse brain, nNOS neurons are also found in the tuberal region of the hypothalamus and, in particular, within the arcuate nucleus of the hypothalamus (ARH) (Sica et al., 2009 ), a kisspeptin neuron-containing structure (Oakley et al., 2009; Navarro and Tena-Sempere, 2011 ) that is adjacent to the median eminence, to which GnRH neurons project. To determine whether kisspeptin neurons also interact morphologically and functionally with nNOS neurons in this hypothalamic region, we performed additional neuroanatomical studies. While only a few kisspeptin-immunoreactive fibers were found in apposition to nNOS neurons in the posterior hypothalamus (PH; Fig. 4 A, D) and dorsomedial hypothalamus (DMH; Fig. 4 B, D) , numerous kisspeptin fibers were apposed to nNOS neurons in the ARH (Fig.  4C,D) . Intriguingly, no GPR54 expression was seen in the ARH (Fig. 4 E, H ) or in the DMH (Fig. 4 E, G) , as revealed by X-gal staining in GPR54-LacZ knock-in mice. In contrast, X-gal staining was found to be abundant in the PH and was mostly seen in nNOS-immunoreactive neurons (Fig. 4 E, F ) .
Kisspeptin promotes the phosphorylation of nNOS on its Ser1412 activation site in the preoptic region, but not in the tuberal region of the hypothalamus
The catalytic activity of nNOS is modulated during the ovarian cycle by posttranslational modifications of the enzyme, such as phosphorylation of the Ser1412 residue (Parkash et al., 2010) , which increases its catalytic activity (Rameau et al., 2007) . Ser1412 phosphorylation of nNOS is maximal in the preoptic region on the afternoon of proestrus, when estrogens exert their positive feedback effects on the GnRH system (Parkash et al., 2010) . To determine whether kisspeptin neurons could play a role in the regulation of these posttranslational modifications, we investigated the effects of an intraperitoneal injection of kisspeptin-10 (1 nmol, 30 min) on nNOS phosphorylation, using a phospho-specific antibody directed against Ser1412-phosphorylated nNOS (P-nNOS). In diestrous mice, in which circulating estrogen levels are low, immunofluorescence analysis demonstrated a striking increase in the proportion of nNOS neurons immunoreactive for P-nNOS following kisspeptin-10 injection (36.8 Ϯ 6.0% in vehicle-injected vs 74.3 Ϯ 4.0% in kisspeptin-10-injected mice, n ϭ 4; Student's t test, p Ͻ 0.01); this effect was restricted to the OVLT-MePO region (Fig.  5A) . Indeed, no induction of nNOS phosphorylation was seen in nNOS neurons in the MS or the AVP (Fig. 6) . Western blot analyses revealed that P-nNOS expression was easily detected as a single band of 165 kDa in protein extracts from the mouse preoptic region (Fig. 5B) , and confirmed the potent stimulatory effect of kisspeptin-10 on nNOS phosphorylation in diestrous mice as seen using immunohistochemistry (Fig. 5A ). Notably, P-nNOS levels induced by kisspeptin-10 treatment in diestrous mice were comparable to those seen in proestrus (Fig. 5B) . In contrast, similar analyses performed in the tuberal region of the hypothalamus clearly showed that kisspeptin-10 failed to stimulate nNOS phosphorylation in this hypothalamic region in diestrous mice (Fig. 7) .
. Kisspeptin-neurons project onto nNOS neurons that do not express GPR54 in the ARH. A-D, Immunofluorescence labeling showing abundant kisspeptin fibers (green) apposed to nNOS neurons (red) in the ARH (C, arrowheads), whereas Kisspeptin-nNOS morphological interactions are less conspicuous in the DMH and the PH (A, B). E, Schematic brain map demonstrating the distribution of nNOS neurons (red) expressing (crosses) or not expressing (circles) GPR54 in the tuberal region of the hypothalamus. Black circles indicate GPR54-expressing cells of unidentified phenotype. F-H, X-gal histochemistry (black dots) revealing GPR54 expression in nNOS neurons (red, arrowheads) in the PH (F), but not in the DMH (G) or in the ARH (H), in which no GPR54 expression is detected. Note that in H,
Estradiol-promoted phosphorylation of nNOS in preoptic neurons requires kisspeptin-GPR54 signaling
To further explore the role of estrogens and kisspeptin in triggering nNOS phosphorylation in preoptic neurons, we performed experiments in ovariectomized (OVX) mice. As shown in Figure 5C , kisspeptin-10 (1 nmol, 30 min, i.p.) was as potent at inducing Ser1412 phosphorylation of nNOS in OVX mice, when compared with controls, as a subcutaneous injection of sesame oil containing 17␤-estradiol 3-benzoate, which mimics the preovulatory increase in plasma estrogens that occurs at proestrus (n ϭ 5 animals per group). To examine whether kisspeptin signaling is necessary for the estrogenmediated activation of nNOS, we then tested the ability of estradiol to promote nNOS phosphorylation in Gpr54-null mice (Seminara et al., 2003) . Western blot analyses clearly showed that estradioltreatment did not induce any change in nNOS phosphorylation in Gpr54-null mice ( p Ͼ 0.05; Fig. 5C ). Together, our results strongly suggest that kisspeptin neurons act directly on NO-synthesizing neurons to promote preovulatory nNOS activation in the preoptic region.
Kisspeptin promotes nNOS phosphorylation via the activation of the PI3K/AKT signaling pathway
To gain further insight into the downstream pathways used by kisspeptin-GPR54 signaling to promote nNOS phosphorylation in preoptic neurons, we investigated whether kisspeptin activation of its cognate receptor is coupled with the activation of the phosphatidylinositol-3 kinase (PI3K)/AKT signaling pathway, which is thought to mediate the phosphorylation of Ser1412 in nNOS (Rameau et al., 2007) and has been shown to be stimulated by GPR54 signaling (Stathatos et al., 2005; Novaira et al., 2009) . We also explored the putative activation of the ERK1/2 signaling pathway, which has been shown to be stimulated by the activation of GPR54 (Castellano et al., 2006) . Immunoblot analysis revealed that kisspeptin-10 (1 nmol, 30 min) stimulated the phosphorylation of nNOS (Fig. 8 A) and AKT (Fig. 8 B) , but not ERK1/2 (Fig. 8C ) in wild-type diestrous mice, and that these effects of kisspeptin were absent in Gpr54-null littermates (n ϭ 4 -5 per group; Fig. 8 A, B) . To determine whether AKT activation is actually required for kisspeptin to exert its stimulatory effects on nNOS phosphorylation, we treated wild-type OVX mice with the PI3K inhibitor LY294002 (100 mg/kg, i.p.) for 30 min before exposing them to kisspeptin-10. As shown in Figure 8 , D and E, the inhibition of PI3K activity abrogated the ability of kisspeptin to induce the phosphorylation both of nNOS and of AKT. In contrast, the treatment of mice with the MAPK inhibitor U0126 (30 mg/kg, i.p.) affected neither nNOS nor AKT phosphorylation (Fig. 8 D, E) , whereas it significantly inhibited the basal phosphorylation of ERK1/2 (Fig. 8 F) . Thus, the activation of the PI3K/AKT signaling pathway is likely to underlie the phosphorylation of nNOS induced by kisspeptin in neurons of the preoptic region.
NO release imposes a tonic brake on LH secretion during the estrogen-mediated negative feedback phase Having shown that kisspeptin and nNOS neurons morphologically and functionally interact in specific regions of the ventral forebrain in which a subset of GnRH neurons reside, we next sought to determine whether this kisspeptin-nNOS neuronal interaction could play a role in the control of LH release. In diestrous mice, treatment with kisspeptin-10 (n ϭ 10) resulted in a robust and significant increase in plasma LH when compared with vehicle-treated animals (n ϭ 9; Fig. 9A ). Inhibiting NOS activity via the intraperitoneal administration of the NOS inhibitor L-NAME (50 mg/kg, i.p.) resulted in a comparable increase in LH release (n ϭ 6; Fig. 9A ). Kisspeptin-10 treatment of L-NAMEtreated animals (n ϭ 10) triggered the release of LH at levels comparable to those seen in proestrus (n ϭ 4; Fig. 9A ). Correspondingly, the treatment of Gpr54-null mice with L-NAME (n ϭ 4) and of nNos-null mice with kisspeptin-10 (n ϭ 4) resulted in the release of similar proestrus-like levels of LH (Fig. 9A) . Altogether, these data reveal that NO exerts a tonic inhibitory effect on GnRH/LH release at stages of the ovarian cycle in which gonadal steroids exert their negative feedback effects.
Neuronal NOS activity is essential for the LH surge
Daily inspection of vaginal cytology in nNos-null mice (n ϭ 7), in which no residual nNOS expression was seen in the preoptic region (Fig. 9B) , revealed an absence of normal estrous cyclicity (Fig. 9C, top) . nNos-null mice exhibited an alternation of persistent periods of vaginal cornification and a persistent diestrous state with the sporadic occurrence of complete 4 -5 d ovarian cycles, whereas wild-type littermates showed regular estrous cyclicity. In contrast to ovaries from wild-type mice (n ϭ 4), which contained large Graafian follicles and corpora lutea, histological inspection of adult nNos-null mouse ovaries (n ϭ 4) revealed the presence of primary and secondary follicles and occasionally an early Graafian follicle, as well as numerous large follicular cysts, but few or no corpora lutea (Fig. 9C, bottom) . These findings show that nNos-null mice display ovarian cyclicity deficits and may present impaired ovulation, as previously suggested (Klein et al., 1998) . The ability of the hypothalamic-pituitary axis to respond to positive feedback by gonadal steroids was tested in mutant mice. While OVX wild-type mice (n ϭ 7) exhibited an LH surge in response to gonadal steroid treatment, only one of five nNos-null littermates exhibited an LH surge ( p Ͻ 0.05; Fig. 9D ). Concordantly, L-NAME treatment to inhibit NOS activity (n ϭ 10) mimicked the effects of the null mutation on the gonadal steroid-induced LH surge in wild-type mice (Fig. 9D, p ϭ 0.003) .
Discussion
We report here that NO-synthesizing neurons are important components of the neural circuit used by estrogens and kisspeptin neurons to trigger the onset of the preovulatory GnRH/LH surge in mice. The use of a genetic strategy to visualize the GPR54-expressing cells targeted by kisspeptin demonstrates that, in addition to GnRH neurons themselves, discrete populations of nNOS neurons abundantly surrounded by kisspeptin fibers also express the kisspeptin receptor GPR54 in the preoptic region. We found that kisspeptin selectively promotes the phosphorylation of nNOS at the Ser1412 activation site by activating the PI3K/AKT signaling pathway in these neurons. A null mutation of Gpr54 prevents both kisspeptin and estradiol effects on nNOS phosphorylation in ovariectomized mice, showing that estrogens require kisspeptin-GPR54 signaling to influence nNOS activity during the ovarian cycle, an effect that is maximal on the day of proestrus when positive feedback comes into play (d'Anglemont de Tassigny et al., 2007a; Parkash et al., 2010; present study) . Correspondingly, mice harboring a null mutation of the nNos gene exhibit a markedly impaired ability to generate an LH surge in response to gonadal steroids, and a conspicuous ovulation deficiency. Together, these observations provide a number of new insights that expand our current understanding of kisspeptin-and NO-mediated regulation of the hypothalamic-pituitary-gonadal axis in adult mammals.
NO, which travels readily across cellular membranes and enters presynaptic and postsynaptic sites, is capable of coordinating neuronal inputs in a restricted brain volume defined by its half-life and diffusion constant (Gally et al., 1990) . Since NO cannot be stored in synaptic vesicles, unlike other neurotransmitters, mechanisms that regulate its synthesis in time and space are crucial in determining its biological effect (Garthwaite, 2008) . In the mouse (Clasadonte et al., 2008; present study) , as in the rat (Grossman et al., 1994; Herbison et al., 1996) , GnRH neurons are surrounded by NO-synthesizing neurons in the basal forebrain, one of the major sites of NOS expression in the CNS (Bredt et al., 1991; Yamada et al., 1996; Edelmann et al., 2007) . The production of neuronal NO in the vicinity of GnRH neurons is tightly regulated by estrogens (d 'Anglemont de Tassigny et al., 2007a; Parkash et al., 2010) and has been shown to directly modulate GnRH neuronal activity (Clasadonte et al., 2008) . The present findings reveal, intriguingly, that NO has a dual effect on GnRH/LH release during the ovarian cycle. Pharmacological and genetic inhibition of nNOS activity significantly increase basal and kisspeptin-stimulated LH release, respectively, in diestrous mice, suggesting that during the negative-feedback phase of estrogen action, a constitutive basal level of NO release maintains the tonic Figure 7 . Kisspeptin fails to promote the phosphorylation of nNOS in the tuberal region of the hypothalamus. A, Immunoblotting demonstrating that kisspeptin-treatment in diestrous mice has no effect on nNOS phosphorylation in the hypothalamic tuberal region. B, Bar graph illustrating the mean ratio of the signal obtained for P-nNOS to that of actin in blots from five independent experiments (n ϭ 5 animals). MBH, Mediobasal hypothalamus. Error bars indicate the SEM.
inhibition of GnRH neurons, keeping LH levels at their nadir. These results are in agreement with data collected from ewes that suggest a role for nitric oxide in the preoptic region in the suppression of GnRH/LH secretion during estrogen-mediated negative feedback in seasonal anoestrus (Stefanovic et al., 2000; McManus et al., 2007) , but stand out from those of a previous study performed in rats, in which the pharmacological inhibition of nNOS failed to alter basal or kisspeptin-evoked LH release (Navarro et al., 2005) . However, sex differences may account for this discrepancy, as the Navarro study was performed using males, and a recent human study has demonstrated that kisspeptin-stimulated LH release is sexually dimorphic (Jayasena et al., 2011) . In contrast, we also show that the blockade of NO synthesis blunts the LH surge in steroid-primed mice, known to involve the activation of kisspeptin-GPR54 signaling (Clarkson et al., 2008) initiated by the kisspeptin neuronal population residing in the anteroventral periventricular nucleus (Clarkson et al., 2008; Gottsch et al., 2009; Mayer et al., 2010) . Together, these results suggest that NO-and kisspeptin-synthesizing neurons interact in synergy to coordinate the progression of the ovarian cycle, and thus reconcile the recent evidence that kisspeptin signaling plays a key role in the neuroendocrine control of reproduction (Funes et al., 2003; Seminara et al., 2003; d'Anglemont de Tassigny et al., 2007b; Dungan et al., 2007; Kauffman et al., 2007; Lapatto et al., 2007; Clarkson et al., 2008; Mayer et al., 2010; Mayer and Boehm, 2011) , with the originally postulated role for NO in controlling GnRH secretion (Rettori et al., 1993; Mahachoklertwattana et al., 1994) , the onset of the preovulatory GnRH/LH surge (Bonavera et al., 1993; Aguan et al., 1996; d'Anglemont de Tassigny et al., 2007a) , and fertility (Gyurko et al., 2002) . These findings also raise the exciting possibility that the estrogen-evoked kisspeptin-mediated activation of nNOS neurons in proestrus serves as an intermediate synchronizing switch for the GnRH system that enables the transition between pulsatile and peak release of GnRH (Christian and Moenter, 2010) . NO could operate such a switch by acting either directly on GnRH neurons (Clasadonte et al., 2008) or on its trans-synaptic inputs (PieleckaFortuna et al., 2008; Zhang et al., 2009; Pielecka-Fortuna and Moenter, 2010) , or both.
A recent study has demonstrated, provocatively, that kisspeptin neurons and GPR54-expressing cells are dispensable for reproductive function when ablated during a certain window early in development (Mayer and Boehm, 2011) , suggesting that the GnRH system can be turned on independently of kisspeptin neurons and kisspeptin/GPR54 signaling. Accordingly, another recent study has demonstrated that an agonist of the NMDA-type glutamate receptor, which triggers puberty, ovulation, and GnRH secretion in both rodents (Urbanski and Ojeda, 1990; Brann and Mahesh, 1991) and primates (Plant et al., 1989; Claypool et al., 2000) , is capable of activating the reproductive axis in both Kiss-and Gpr54-null mice, and that these effects may involve nNOS neurons (d'Anglemont de . Since most nNOS neurons of the preoptic region express the NMDA receptor (d'Anglemont de Tassigny et al., 2007a) and estrogen receptor ␣ (Scordalakes et al., 2002; Sato et al., 2005) , both of which are critical for the estrogen positive-feedback effect on GnRH neurons (Brann and Mahesh, 1991; Wintermantel et al., 2006) and nNOS activity (d'Anglemont de Tassigny et al., 2007a , it is tempting to speculate that nNOS neurons may be involved in the cellular mechanisms underlying compensation in animals in which neurons mediating kisspeptin/GPR54 signaling are absent (Mayer and Boehm, 2011) . Estrogens may indeed regulate Intriguingly, our immunofluorescence experiments demonstrated that the systemic administration of kisspeptin selectively induces nNOS phosphorylation in an area proximal to the OVLT, a brain area devoid of a blood-brain barrier (Broadwell and Brightman, 1976; Ciofi et al., 2009 ) and containing numerous kisspeptin fibers and nNOS neurons (present paper), and to which GnRH neurons have recently been shown to extend dendrites (Herde et al., 2011; Prevot, 2011) . Even though the peripheral administration of kisspeptin-10 is effective in promoting GnRH/LH release, our data suggest that this variant of kisspeptin does not readily cross the blood-brain barrier and thus fails to target all hypothalamic GPR54-expressing neurons in our experimental paradigm. This important caveat notwithstanding, our studies raise the interesting possibility that the OVLT may be a privileged site for interactions between kisspeptin, nNOS, and GnRH neurons in the neuroendocrine brain.
In addition to modulating GnRH neuronal activity within the preoptic region, accumulating evidence suggests that NO is involved in the control of GnRH release within the median eminence, the termination field of GnRH neuroendocrine neurons (Rettori et al., 1993; Knauf et al., 2001; de Seranno et al., 2004 de Seranno et al., , 2010 , and another brain site that lies outside of the blood-brain barrier (Ciofi et al., 2009; Mullier et al., 2010) . Because kisspeptin has also been shown to stimulate GnRH release from hypothalamic explants containing both the median eminence and the ARH (d'Anglemont de , and because arcuate nNOS neurons reside adjacent to the median eminence (Sica et al., 2009 ), one could argue that a part of the effects observed on LH secretion after the systemic administration of kisspeptin and Figure 9 . Kisspeptin-nNOS interactions are required for the neuroendocrine control of reproduction. A, Basal nNOS activity maintains the tonic inhibition on the GnRH system during the estrogen-mediated negative feedback phase, as assessed by LH release in wild-type and Gpr54-and nNOS-null mice in the presence or absence on the NOS inhibitor L-NAME. Values represent means Ϯ SEM. *p Ͻ 0.05, **p Ͻ 0.005; experimental groups versus untreated controls. B, Western blot analysis showing the absence of nNOS protein expression in nNOS-null mice. C, Top, nNOS-null mice do not exhibit normal estrous cyclicity as do wild-type mice, but instead enter prolonged periods of diestrus. nNOS-null mice sometimes display isolated complete cycles; however, these are often followed by prolonged periods of acyclicity. C, Cornified (estrus); N, nucleated (proestrus); L, lymphocytic (diestrus). Bottom, Histology of ovaries from nNOS-null mice reveals a greater number of atretic follicles and the relative paucity or absence of corpora lutea (CL) when compared with the ovaries of wild-type littermates in which follicular development is normal. D, nNOS activity is required for the onset of the gonadal steroid-evoked LH surge in ovariectomized animals. IB, Immunoblot; ND, not determined.
L-NAME in wild-type and nNos-null animals could be due to an alteration of nNOS activity in these arcuate neurons. However, by showing both that kisspeptin fails to modulate nNOS phosphorylation in the tuberal region of the hypothalamus and, in agreement with a previous study (Herbison et al., 2010) , that nNOS neurons of the ARH do not express any detectable GPR54 promoter activity, our data clearly suggest that this population of nNOS neurons is unable to respond directly to kisspeptin. Yet the possibility remains that the kisspeptin neurons intimately associated with nNOS neurons in the ARH communicate through other signaling pathways, such as those involving dynorphin and neurokinin B, two transmitters coexpressed with kisspeptin (Ciofi et al., 2006 Goodman et al., 2007; Hrabovszky et al., 2010) and that have been postulated to drive short feedback loops within the tuberal region of the hypothalamus to control the rhythmic discharge of kisspeptin and induce the release of GnRH from fibers in the median eminence Wakabayashi et al., 2010) .
Together, the results presented here identify preoptic nNOS neurons as an integral component of the neural network controlling ovarian cyclicity and ovulation and indicate that the production of NO may play an important and hitherto unappreciated role in the kisspeptin-dependent preovulatory activation of GnRH neurons. NO could potentially be used by kisspeptin neurons to facilitate synchronous activity among GnRH neurons that were previously operating independently and ultimately to maximize the release of this neurohormone into the blood.
